Zusammenfassung
Der vorliegende Artikel gibt eine Übersicht über neue Entwicklungen der Diagnostik des nodulären lymphozytenprädominanten Hodgkin-Lymphoms unter Berücksichtigung der revidierten Version der WHO-Klassifikation 2016. Besondere Themen sind die Differenzialdiagnosen einer progressiven Keimzentrumstransformation, das T‑Zell-/histiozytenreiche großzellige B‑Zell-Lymphom sowie die Transformation in ein diffuses großzelliges B‑Zell-Lymphom.
Abstract
The present article gives an overview of novel developments in the diagnosis of nodular lymphocyte predominant Hodgkin’s lymphoma with reference to the revised WHO classification from 2016. Differential diagnoses that are discussed are progressively transformed germinal centers, T cell/histiocyte-rich large B cell lymphoma as well as transformation into a diffuse large B cell lymphoma.
Literatur
Anagnostopoulos I, Hansmann ML, Franssila K, Harris M, Harris NL, Jaffe ES, Han J, van Krieken JM, Poppema S, Marafioti T, Franklin J, Sextro M, Diehl V et al (2000) European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 96(5):1889–1899
Saarinen S, Pukkala E, Vahteristo P, Makinen MJ, Franssila K, Aaltonen LA (2013) High familial risk in nodular lymphocyte-predominant Hodgkin lymphoma. J Clin Oncol 31(7):938–943. doi:10.1200/jco.2012.43.5958
Eichenauer DA, Plutschow A, Fuchs M, von Tresckow B, Boll B, Behringer K, Diehl V, Eich HT, Borchmann P, Engert A (2015) Long-term course of patients with stage IA nodular lymphocyte-predominant Hodgkin Lymphoma: a report from the German Hodgkin study group. J Clin Oncol 33(26):2857–2862. doi:10.1200/jco.2014.60.4363.
Strobbe L, Valke LL, Diets IJ, van den Brand M, Aben K, Raemaekers JM, Hebeda KM, van Krieken JH (2016) A 20-year population-based study on the epidemiology, clinical features, treatment, and outcome of nodular lymphocyte predominant Hodgkin lymphoma. Ann Hematol 95(3):417–423. doi:10.1007/s00277-015-2578-6.
Xing KH, Connors JM, Lai A, Al-Mansour M, Sehn LH, Villa D, Klasa R, Shenkier T, Gascoyne RD, Skinnider B, Savage KJ (2014) Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis. Blood 123(23):3567–3573. doi:10.1182/blood-2013-12-541078
Kenderian SS, Habermann TM, Macon WR, Ristow KM, Ansell SM, Colgan JP, Johnston PB, Inwards DJ, Markovic SN, Micallef IN, Thompson CA, Porrata LF, Martenson JA et al (2016) Large B‑cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution. Blood 127(16):1960–1966. doi:10.1182/blood-2015-08-665505
Shankar AG, Kirkwood AA, Hall GW, Hayward J, O’Hare P, Ramsay AD (2015) Childhood and adolescent nodular lymphocyte predominant Hodgkin lymphoma – a review of clinical outcome based on the histological variants. Br J Haematol 171(2):254–262. doi:10.1111/bjh.13540
Mauz-Korholz C, Gorde-Grosjean S, Hasenclever D, Shankar A, Dorffel W, Wallace WH, Schellong G, Robert A, Korholz D, Oberlin O, Hall GW, Landman-Parker J (2007) Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma. Cancer 110(1):179–185. doi:10.1002/cncr.22762
Hartmann S, Eichenauer DA, Plutschow A, Mottok A, Bob R, Koch K, Bernd HW, Cogliatti S, Hummel M, Feller AC, Ott G, Moller P, Rosenwald A et al (2013) The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood 122(26):4246–4252. doi:10.1182/blood-2013-07-515825
Hartmann S, Eichenauer DA, Plutschow A, Mottok A, Bob R, Koch K, Bernd HW, Cogliatti S, Hummel M, Feller AC, Ott G, Moller P, Rosenwald A et al (2014) Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma – a matched pair analysis from the German Hodgkin Study Group (GHSG). Br J Haematol 167(2):238–242. doi:10.1111/bjh.12997
Nathwani B, Vornanen M, Winkelmann R, Kansal R, Döring C, Hartmann S, Hansmann ML (2013) Intranodular clusters of activated cells with T follicular helper (TFH) phenotype in nodular lymphocyte predominant Hodgkin Lymphoma: a pilot study of 32 cases from Finland. Hum Pathol 44(9):1737–1746. doi:10.1016/j.humpath.2013.02.010
Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA (2003) Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol 27(10):1346–1356
Quintanilla-Martinez L, Fend F, Moguel LR, Spilove L, Beaty MW, Kingma DW, Raffeld M, Jaffe ES (1999) Peripheral T‑cell lymphoma with Reed-Sternberg-like cells of B‑cell phenotype and genotype associated with Epstein-Barr virus infection. Am J Surg Pathol 23(10):1233–1240
Moroch J, Copie-Bergman C, de Leval L, Plonquet A, Martin-Garcia N, Delfau-Larue MH, Molinier-Frenkel V, Belhadj K, Haioun C, Audouin J, Swerdlow SH, Marafioti T, Gaulard P (2012) Follicular peripheral T‑cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics. Am J Surg Pathol 36(11):1636–1646. doi:10.1097/PAS.0b013e318268d9
Huppmann AR, Nicolae A, Slack GW, Pittaluga S, Davies-Hill T, Ferry JA, Harris NL, Jaffe ES, Hasserjian RP (2014) EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults. Am J Surg Pathol 38(3):316–324. doi:10.1097/PAS.0000000000000107
Hartmann S, Eray M, Doring C, Lehtinen T, Brunnberg U, Kujala P, Vornanen M, Hansmann ML (2014) Diffuse large B cell lymphoma derived from nodular lymphocyte predominant Hodgkin lymphoma presents with variable histopathology. BMC Cancer 14(1):332. doi:10.1186/1471-2407-14-332
Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375–2390. doi:10.1182/blood-2016-01-643569
Sato Y, Inoue D, Asano N, Takata K, Asaoku H, Maeda Y, Morito T, Okumura H, Ishizawa S, Matsui S, Miyazono T, Takeuchi T, Kuroda N et al (2012) Association between IgG4-related disease and progressively transformed germinal centers of lymph nodes. Mod Pathol 25(7):956–967. doi:10.1038/modpathol.2012.54
Hartmann S, Winkelmann R, Metcalf RA, Treetipsatit J, Warnke RA, Natkunam Y, Hansmann ML (2015) Immunoarchitectural patterns of progressive transformation of germinal centers with and without nodular lymphocyte-predominant Hodgkin lymphoma. Hum Pathol 46(11):1655–1661. doi:10.1016/j.humpath.2015.07.006
Nam-Cha SH, Roncador G, Sanchez-Verde L, Montes-Moreno S, Acevedo A, Dominguez-Franjo P, Piris MA (2008) PD-1, a follicular T‑cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma. Am J Surg Pathol 32(8):1252–1257. doi:10.1097/pas.0b013e318165b0d6.
Churchill HR, Roncador G, Warnke RA, Natkunam Y (2010) Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis. Hum Pathol 41(12):1726–1734. doi:10.1016/j.humpath.2010.05.010
Brune V, Tiacci E, Pfeil I, Doring C, Eckerle S, van Noesel CJ, Klapper W, Falini B, von Heydebreck A, Metzler D, Brauninger A, Hansmann ML, Kuppers R (2008) Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med 205(10):2251–2268
Hartmann S, Doring C, Jakobus C, Rengstl B, Newrzela S, Tousseyn T, Sagaert X, Ponzoni M, Facchetti F, de Wolf-Peeters C, Steidl C, Gascoyne R, Kuppers R et al (2013) Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma – endpoints of a spectrum of one disease? PLOS ONE 8(11):e78812. doi:10.1371/journal.pone.0078812
Hartmann S, Doring C, Vucic E, Chan FC, Ennishi D, Tousseyn T, de Wolf-Peeters C, Perner S, Wlodarska I, Steidl C, Gascoyne RD, Hansmann ML (2015) Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma. Br J Haematol 169(3):415–422. doi:10.1111/bjh.13310
Scheidt V, Hansmann ML, Schuhmacher B, Döring C, Hartmann S (2016) Atypical variants of nodular lymphocyte predominant Hodgkin lymphoma show low microvessel density and vessels of distention type. Hum Pathol. doi:10.1016/j.humpath.2016.10.008
Al-Mansour M, Connors JM, Gascoyne RD, Skinnider B, Savage KJ (2010) Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin’s lymphoma. J Clin Oncol 28(5):793–799. doi:10.1200/jco.2009.24.9516
Biasoli I, Stamatoullas A, Meignin V, Delmer A, Reman O, Morschhauser F, Coiffier B, Bosly A, Divine M, Brice P (2010) Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B‑cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group. Cancer 116(3):631–639. doi:10.1002/cncr.24819
Eyre TA, Gatter K, Collins GP, Hall GW, Watson C, Hatton CS (2015) Incidence, management, and outcome of high-grade transformation of nodular lymphocyte predominant Hodgkin lymphoma: long-term outcomes from a 30-year experience. Am J Hematol 90(6):E103–E110. doi:10.1002/ajh.23989
Hansmann ML, Stein H, Fellbaum C, Hui PK, Parwaresch MR, Lennert K (1989) Nodular paragranuloma can transform into high-grade malignant lymphoma of B type. Hum Pathol 20(12):1169–1175
Huang JZ, Weisenburger DD, Vose JM, Greiner TC, Aoun P, Chan WC, Lynch JC, Bierman PJ, Armitage JO (2004) Diffuse large B‑cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group. Leuk Lymphoma 45(8):1551–1557. doi:10.1080/1042819031000149421
Hartmann S, Schuhmacher B, Rausch T, Fuller L, Doring C, Weniger M, Lollies A, Weiser C, Thurner L, Rengstl B, Brunnberg U, Vornanen M, Pfreundschuh M et al (2016) Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma. Leukemia 30(4):844–853. doi:10.1038/leu.2015.328
Schuhmacher B, Rengstl B, Doring C, Bein J, Newrzela S, Brunnberg U, Kvasnicka HM, Vornanen M, Kuppers R, Hansmann ML, Hartmann S (2016) A strong host response and lack of MYC expression are characteristic for diffuse large B cell lymphoma transformed from nodular lymphocyte predominant Hodgkin lymphoma. Oncotarget. doi:10.18632/oncotarget.12363
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Interessenkonflikt
S. Hartmann und M.-L. Hansmann geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Additional information
Redaktion
H.A. Baba, Essen
Rights and permissions
About this article
Cite this article
Hartmann, S., Hansmann, ML. Update zum nodulären lymphozytenprädominanten Hodgkin-Lymphom und verwandten Läsionen. Pathologe 38, 3–10 (2017). https://doi.org/10.1007/s00292-016-0257-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00292-016-0257-6
Schlüsselwörter
- Histopathologische Wachstumsmuster
- T‑Zell-reiches/Histiozyten-reiches B‑Zell Lymphom
- Progressive Keimzentrumstransformation
- Diffuses großzelliges B‑Zell-Lymphom